{{Rsnum
|rsid=17183114
|Chromosome=4
|position=181301574
|Orientation=plus
|GMAF=0.1065
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 73.5 | 24.8 | 1.8
| HCB | 94.2 | 5.8 | 0.0
| JPT | 88.5 | 11.5 | 0.0
| YRI | 83.0 | 17.0 | 0.0
| ASW | 78.6 | 21.4 | 0.0
| CHB | 94.2 | 5.8 | 0.0
| CHD | 93.6 | 6.4 | 0.0
| GIH | 96.0 | 4.0 | 0.0
| LWK | 82.7 | 17.3 | 0.0
| MEX | 80.4 | 19.6 | 0.0
| MKK | 84.0 | 14.7 | 1.3
| TSI | 79.4 | 17.6 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=T
  |Pval=8E-6
  |OR=26.49
  |ORtxt=[14.89-38.09] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}